JMVNX
Price
$14.58
Change
-$0.25 (-1.69%)
Updated
Jun 13 closing price
Net Assets
1.33B
VEVYX
Price
$44.71
Change
-$0.54 (-1.19%)
Updated
Jun 13 closing price
Net Assets
17.34B
Interact to see
Advertisement

JMVNX vs VEVYX

Header iconJMVNX vs VEVYX Comparison
Open Charts JMVNX vs VEVYXBanner chart's image
JHFunds2 Mid Value NAV
Price$14.58
Change-$0.25 (-1.69%)
VolumeN/A
Net Assets1.33B
Victory Sycamore Established Value Y
Price$44.71
Change-$0.54 (-1.19%)
VolumeN/A
Net Assets17.34B
JMVNX vs VEVYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JMVNX vs. VEVYX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVNX is a Hold and VEVYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEVYX has more cash in the bank: 17.3B vs. JMVNX (1.33B). JMVNX pays higher dividends than VEVYX: JMVNX (1.30) vs VEVYX (1.12). JMVNX was incepted earlier than VEVYX: JMVNX (16 years) vs VEVYX (12 years). JMVNX (0.96) is less costly to investors than VEVYX (0.66). JMVNX is a more actively managed with annual turnover of: 46.00 vs. VEVYX (34.00). JMVNX has a lower initial minimum investment than VEVYX: JMVNX (0) vs VEVYX (1000000). VEVYX annual gain was more profitable for investors over the last year : -6.53 vs. JMVNX (-14.75). VEVYX return over 5 years is better than : 40.61 vs. JMVNX (14.74).
JMVNXVEVYXJMVNX / VEVYX
Total Expense Ratio0.950.66144%
Annual Report Gross Expense Ratio0.960.66145%
Fund Existence16 years12 years-
Gain YTD-4.268-2.497171%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B17.3B8%
Annual Yield % from dividends1.301.12116%
Returns for 1 year-14.75-6.53226%
Returns for 3 years-11.404.61-247%
Returns for 5 years14.7440.6136%
Returns for 10 years-3.1442.12-7%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX44.210.19
+0.43%
MoonLake Immunotherapeutics
RYI20.78-0.47
-2.21%
RYERSON HOLDING Corp
SWK65.26-2.16
-3.20%
Stanley Black & Decker
NMRA0.84-0.05
-5.94%
Neumora Therapeutics
DWTX4.65-0.53
-10.23%
Dogwood Therapeutics Inc